Crown Castle Inc. (LON:0I4W)
106.81
+1.66 (1.58%)
At close: Aug 1, 2025
Intra-Cellular Therapies Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Rental Revenue | 6,245 | 6,358 | 6,532 | 6,289 | 5,719 | 5,320 | Upgrade |
Other Revenue | 223 | 210 | 449 | 697 | 621 | 520 | Upgrade |
6,468 | 6,568 | 6,981 | 6,986 | 6,340 | 5,840 | Upgrade | |
Revenue Growth (YoY | 6.36% | -5.92% | -0.07% | 10.19% | 8.56% | 1.34% | Upgrade |
Property Expenses | 1,845 | 1,847 | 1,980 | 2,068 | 1,993 | 1,949 | Upgrade |
Selling, General & Administrative | 648 | 706 | 759 | 750 | 680 | 678 | Upgrade |
Depreciation & Amortization | 1,719 | 1,738 | 1,754 | 1,707 | 1,644 | 1,608 | Upgrade |
Total Operating Expenses | 4,212 | 4,291 | 4,493 | 4,525 | 4,317 | 4,235 | Upgrade |
Operating Income | 2,256 | 2,277 | 2,488 | 2,461 | 2,023 | 1,605 | Upgrade |
Interest Expense | -956 | -932 | -850 | -699 | -657 | -689 | Upgrade |
Interest & Investment Income | 18 | 19 | 15 | 3 | 1 | 2 | Upgrade |
Other Non-Operating Income | -28 | -28 | -6 | -10 | -21 | -5 | Upgrade |
EBT Excluding Unusual Items | 1,290 | 1,336 | 1,647 | 1,755 | 1,346 | 913 | Upgrade |
Merger & Restructuring Charges | - | - | -1 | -2 | -1 | -10 | Upgrade |
Impairment of Goodwill | -4,958 | -4,958 | - | - | - | - | Upgrade |
Asset Writedown | -144 | -148 | -33 | -34 | -21 | -74 | Upgrade |
Other Unusual Items | - | - | - | -28 | -145 | 267 | Upgrade |
Pretax Income | -3,891 | -3,879 | 1,528 | 1,691 | 1,179 | 1,076 | Upgrade |
Income Tax Expense | 22 | 24 | 26 | 16 | 21 | 20 | Upgrade |
Earnings From Continuing Operations | -3,913 | -3,903 | 1,502 | 1,675 | 1,158 | 1,056 | Upgrade |
Earnings From Discontinued Operations | -725 | - | - | - | -62 | - | Upgrade |
Net Income to Company | -4,638 | -3,903 | 1,502 | 1,675 | 1,096 | 1,056 | Upgrade |
Net Income | -4,638 | -3,903 | 1,502 | 1,675 | 1,096 | 1,056 | Upgrade |
Preferred Dividends & Other Adjustments | - | - | - | - | - | 57 | Upgrade |
Net Income to Common | -4,638 | -3,903 | 1,502 | 1,675 | 1,096 | 999 | Upgrade |
Net Income Growth | - | - | -10.33% | 52.83% | 3.79% | 22.79% | Upgrade |
Basic Shares Outstanding | 435 | 434 | 434 | 433 | 432 | 423 | Upgrade |
Diluted Shares Outstanding | 435 | 434 | 434 | 434 | 434 | 425 | Upgrade |
Shares Change (YoY) | -0.06% | - | - | - | 2.12% | 1.68% | Upgrade |
EPS (Basic) | -10.67 | -8.99 | 3.46 | 3.87 | 2.54 | 2.36 | Upgrade |
EPS (Diluted) | -10.67 | -8.99 | 3.46 | 3.86 | 2.53 | 2.35 | Upgrade |
EPS Growth | - | - | -10.36% | 52.74% | 7.54% | 31.29% | Upgrade |
Dividend Per Share | 5.758 | 6.260 | 6.260 | 5.980 | 5.460 | 4.930 | Upgrade |
Dividend Growth | -8.03% | - | 4.68% | 9.52% | 10.75% | 7.64% | Upgrade |
Operating Margin | 34.88% | 34.67% | 35.64% | 35.23% | 31.91% | 27.48% | Upgrade |
Profit Margin | -71.71% | -59.42% | 21.52% | 23.98% | 17.29% | 17.11% | Upgrade |
EBITDA | 3,933 | 3,973 | 4,197 | 4,119 | 3,613 | 3,155 | Upgrade |
EBITDA Margin | 60.81% | 60.49% | 60.12% | 58.96% | 56.99% | 54.02% | Upgrade |
D&A For Ebitda | 1,677 | 1,696 | 1,709 | 1,658 | 1,590 | 1,550 | Upgrade |
EBIT | 2,256 | 2,277 | 2,488 | 2,461 | 2,023 | 1,605 | Upgrade |
EBIT Margin | 34.88% | 34.67% | 35.64% | 35.23% | 31.91% | 27.48% | Upgrade |
Effective Tax Rate | - | - | 1.70% | 0.95% | 1.78% | 1.86% | Upgrade |
Revenue as Reported | 6,468 | 6,568 | 6,981 | 6,986 | 6,340 | 5,840 | Upgrade |
Updated Mar 14, 2025. Source: S&P Global Market Intelligence. Real Estate template. Financial Sources.